Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tonix Pharma (TNXP)
NASDAQ:TNXP
Tonix Pharma (TNXP) Stock Price & Analysis
2,302 Followers
TNXP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.12 - $2.10
Previous Close$0.19
Volume2.97M
Average Volume (3M)2.56M
Market Cap
$17.45M
Enterprise Value$12.39M
Total Cash (Recent Filing)$6.91M
Total Debt (Recent Filing)$1.15M
Price to Earnings (P/E)>-0.1
Beta2.74
Next Earnings
Aug 05, 2024EPS Estimate
-$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.55
Shares Outstanding95,543,805
10 Day Avg. Volume2,325,380
30 Day Avg. Volume2,564,534
Standard Deviation0.37
R-Squared0.10
Alpha-0.12
Financial Highlights & Ratios
Price to Book (P/B)0.17
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.11
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.25
Forecast
1Y Price Target
$2.25Price Target Upside1132.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Tonix Pharma News
Ownership Overview
9.14%
Insiders
0.59% Mutual Funds
9.69% Other Institutional Investors
80.58% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TNXP FAQ
What was Tonix Pharma’s price range in the past 12 months?
Tonix Pharma lowest stock price was $0.12 and its highest was $2.10 in the past 12 months.
What is Tonix Pharma’s market cap?
Currently, no data Available
When is Tonix Pharma’s upcoming earnings report date?
Tonix Pharma’s upcoming earnings report date is Aug 05, 2024 which is in 76 days.
How were Tonix Pharma’s earnings last quarter?
Currently, no data Available
Is Tonix Pharma overvalued?
According to Wall Street analysts Tonix Pharma’s price is currently Undervalued.
Does Tonix Pharma pay dividends?
Tonix Pharma does not currently pay dividends.
What is Tonix Pharma’s EPS estimate?
Tonix Pharma’s EPS estimate is -$0.26.
How many shares outstanding does Tonix Pharma have?
Tonix Pharma has 95,543,810 shares outstanding.
What happened to Tonix Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tonix Pharma?
Currently, no hedge funds are holding shares in TNXP
---
Tonix Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.25 (1132.20% Upside)
$2.25 (1132.20% Upside)
Blogger Sentiment
Neutral
TNXP Sentiment 50%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.5%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.67%
12-Months-Change
Fundamentals
Return on Equity
-72.08%
Trailing 12-Months
Asset Growth
-24.43%
Trailing 12-Months
Company Description
Tonix Pharma
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.
---
TNXP Stock 12 Month Forecast
Average Price Target
$2.25
▲(1132.20% Upside)
Technical Analysis
Best Analysts Covering TNXP
1 Year
1 Year Success Rate
1/15 ratings generated profit
1 Year Average Return
-75.80%
reiterated a buy rating last month
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 6.67% of your transactions generating a profit, with an average return of -75.80% per trade.
---